Peripheral Blood Cytokine Profiling During Pregnancy and Post-partum Periods

American Journal of Reproductive Immunology

Volumn 64, Issue 6, 2010, Pages 411-426

  Kraus, Thomas A ^a   Sperling, Rhoda S ^a   Engel, Stephanie M ^a   Lo, Yungtai ^a   Kellerman, Lisa ^a   Singh, Tricia ^a   Loubeau, Martine ^a   Ge, Yongchao ^a   Garrido, Jose L ^a   Rodríguez García, Marta ^a   Moran, Thomas M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Immunity; Reproduction; Serum; Systemic

Indexed keywords

EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; CELL CULTURE; FEMALE; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; STEADY STATE;

ADULT; CELLS, CULTURED; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; ORTHOMYXOVIRIDAE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TH1-TH2 BALANCE;

EID: 77958536100     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00889.x     Document Type: Article

References (53)

1. Ostensen M, Villiger PM: The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 2007; 29:185-191.
2. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S: Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 2006; 22:234-241.
3. Harris J: Influenza occurring in pregnant women. J Am Med Assoc 1919; 72:978-980.
4. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR: Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148:1094-1102.
5. Braden CR: Listeriosis. Pediatr Infect Dis J 2003; 22:745-746.
6. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
7. Sacks GP, Redman CW, Sargent IL: Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 2003; 131:490-497.
8. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178:5949-5956.
9. Sargent IL, Borzychowski AM, Redman CW: NK cells and human pregnancy - an inflammatory view. Trends Immunol 2006; 27:399-404.
10. Smarason AK, Gunnarsson A, Alfredsson JH, Valdimarsson H: Monocytosis and monocytic infiltration of decidua in early pregnancy. J Clin Lab Immunol 1986; 21:1-5.
11. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM: Inflammatory processes in preterm and term parturition. J Reprod Immunol 2008; 79:50-57.
12. Moltedo B, Lopez CB, Pazos M, Becker MI, Hermesh T, Moran TM: Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol 2009; 183:3569-3573.
13. Salazar-Mather TP, Hokeness KL: Cytokine and chemokine networks: pathways to antiviral defense. Curr Top Microbiol Immunol 2006; 303:29-46.
14. Aiba S: Maturation of dendritic cells induced by cytokines and haptens. Tohoku J Exp Med 1998; 184:159-172.
15. Kurokawa M, Imakita M, Kumeda CA, Shiraki K: Cascade of fever production in mice infected with influenza virus. J Med Virol 1996; 50:152-158.
16. De Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203-1207.
17. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P, Martin-Loeches I, Varillas D, Gallegos MC, Seron C, Micheloud D, Gomez JM, Tenorio-Abreu A, Ramos MJ, Molina ML, Huidobro S, Sanchez E, Gordon M, Fernandez V, Del Castillo A, Marcos MA, Villanueva B, Lopez CJ, Rodriguez-Dominguez M, Galan JC, Canton R, Lietor A, Rojo S, Eiros JM, Hinojosa C, Gonzalez I, Torner N, Banner D, Leon A, Cuesta P, Rowe T, Kelvin DJ: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009; 13:R201.
18. Jiang B, Snipes-Magaldi L, Dennehy P, Keyserling H, Holman RC, Bresee J, Gentsch J, Glass RI: Cytokines as mediators for or effectors against rotavirus disease in children. Clin Diagn Lab Immunol 2003; 10:995-1001.
19. Fossum C: Cytokines as markers for infections and their effect on growth performance and well-being in the pig. Domest Anim Endocrinol 1998; 15:439-444.
20. Browning LM, Krebs JD, Magee EC, Fruhbeck G, Jebb SA: Circulating markers of inflammation and their link to indices of adiposity. Obes Facts 2008; 1:259-265.
21. Wong E, Freiberg M, Tracy R, Kuller L: Epidemiology of cytokines: the women on the move through activity and nutrition (WOMAN) study. Am J Epidemiol 2008; 168:443-453.
22. Scheller J, Ohnesorge N, Rose-John S: Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 2006; 63:321-329.
23. Yajnik CS, Joglekar CV, Lubree HG, Rege SS, Naik SS, Bhat DS, Uradey B, Raut KN, Shetty P, Yudkin JS: Adiposity, inflammation and hyperglycaemia in rural and urban Indian men: Coronary Risk of Insulin Sensitivity in Indian Subjects (CRISIS) Study. Diabetologia 2008; 51:39-46.
24. Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS: Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008; 17:3450-3456.
25. Knudsen LS, Christensen IJ, Lottenburger T, Svendsen MN, Nielsen HJ, Nielsen L, Horslev-Petersen K, Jensen JE, Kollerup G, Johansen JS: Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis. Biomarkers 2008; 13:59-78.
26. Ho GY, Xue XN, Burk RD, Kaplan RC, Cornell E, Cushman M: Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2-years in young women. Cytokine 2005; 30:1-6.
27. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95:14863-14868.
28. Everitt B, Landau S, Leese M: Cluster Analysis, 4th edn. New York, Oxford University Press Inc., 2001.
29. Ihaka R, Gentleman R: R: a language for data analysis and graphics. J Comput Graph Stat 1996; 5:299-314.
30. Team RDC: R: A language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria 2004. (accessed on 10 March 2010)
31. Twisk J, Rijmen F: Longitudinal tobit regression: a new approach to analyze outcome variables with floor or ceiling effects. J Clin Epidemiol 2009; 62:953-958.
32. Rosner B: Fundamentals of Biostatistics, 5th edn. Pacific Grove, CA, Duxbury Press, 1999.
33. Lygnos MC, Pappa KI, Papadaki HA, Relakis C, Koumantakis E, Anagnou NP, Eliopoulos GD: Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo 2006; 20:157-163.
34. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N: Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152:4149-4156.
35. Sone H, Kawakami Y, Sakauchi M, Nakamura Y, Takahashi A, Shimano H, Okuda Y, Segawa T, Suzuki H, Yamada N: Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 2001; 281:562-568.
36. Whitcomb BW, Schisterman EF, Luo X, Chegini N: Maternal serum granulocyte colony-stimulating factor levels and spontaneous preterm birth. J Womens Health (Larchmt) 2009; 18:73-78.
37. Goldenberg RL, Andrews WW, Mercer BM, Moawad AH, Meis PJ, Iams JD, Das A, Caritis SN, Roberts JM, Miodovnik M, Menard K, Thurnau G, Dombrowski MP, McNellis D: The preterm prediction study: granulocyte colony-stimulating factor and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000; 182:625-630.
38. Hunt JS, Chen HL, Miller L: Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 1996; 54:554-562.
39. Salmon JE, Alpert D: Are we coming to terms with tumor necrosis factor inhibition in pregnancy? Arthritis Rheum 2006; 54:2353-2355.
40. Pavlov VA, Tracey KJ: The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005; 19:493-499.
41. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-462.
42. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384-388.
43. Altavilla D, Guarini S, Bitto A, Mioni C, Giuliani D, Bigiani A, Squadrito G, Minutoli L, Venuti FS, Messineo F, De Meo V, Bazzani C, Squadrito F: Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects against splanchic artery occlusion shock. Shock 2006; 25:500-506.
44. Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H: MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 2009; 31:965-973.
45. Fernandez-Botran R: Soluble cytokine receptors: their role in immunoregulation. FASEB J 1991; 5:2567-2574.
46. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y: Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003; 88:2348-2351.
47. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658.
48. Suarez A, Castro P, Alonso R, Mozo L, Gutierrez C: Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003; 75:711-717.
49. Altarescu G, Zimran A, Michelakakis H, Elstein D: TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease. Cytokine 2005; 31:149-152.
50. Virgin HW, Wherry EJ, Ahmed R: Redefining chronic viral infection. Cell 2009; 138:30-50.
51. Hermesh T, Moltedo B, Moran TM, Lopez CB: Anti-viral instruction of bone marrow leukocytes during respiratory virus infection. Cell Host Microbe 2010; 7:343-353.
52. Phipps-Yonas H, Seto J, Sealfon SC, Moran TM, Fernandez-Sesma A: Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog 2008; 4:e1000193.
53. Borderia AV, Hartmann BM, Fernandez-Sesma A, Moran TM, Sealfon SC: Antiviral-activated dendritic cells: a paracrine-induced response state. J Immunol 2008; 181:6872-6881.